학술논문

In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells
Document Type
Article
Source
In: Cellular Oncology. (Cellular Oncology, 1 December 2018, 41(6):677-686)
Subject
Language
English
ISSN
22113436
22113428